The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 115K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campos-Lima, P.-O. d.
Right arrow Articles by Masucci, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campos-Lima, P.-O. d.
Right arrow Articles by Masucci, M. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1997/7/83/ $5.00
The Journal of Experimental Medicine, Volume 186, Number 1, July 7, 1997 83-89


Articles

Epitope-dependent Selection of Highly Restricted or Diverse T Cell Receptor Repertoires in Response to Persistent Infection by Epstein-Barr Virus

Pedro-Otavio de Campos-Lima*, Victor Levitsky*, Martha P. Imreh*, Riccardo Gavioli{ddagger}, and Maria G. Masucci*

From the * Microbiology and Tumor Biology Center, Karolinska Institute, S-171 77, Stockholm, Sweden; and {ddagger} Institute of Biochemistry and Molecular Biology, University of Ferrara Medical School, 44100 Ferrara, Italy

The T cell receptor (TCR) repertoires of cytotoxic responses to the immunodominant and subdominant HLA A11–restricted epitopes in the Epstein-Barr virus (EBV) nuclear antigen-4 were investigated in four healthy virus carriers. The response to the subdominant epitope (EBNA4 399-408, designated AVF) was highly restricted with conserved Vβ usage and identical length and amino acid motifs in the third complementarity-determining regions (CDR3), while a broad repertoire using different combinations of TCR-{alpha}/β V and J segments and CDR3 regions was selected by the immunodominant epitope (EBNA4 416-424, designated IVT). Distinct patterns of interaction with the A11–peptide complex were revealed for each AVF- or IVT-specific TCR clonotype by alanine scanning mutagenesis analysis. Blocking of cytotoxic function by antibodies specific for the CD8 coreceptor indicated that, while AVF-specific TCRs are of high affinity, the oligoclonal response to the IVT epitope includes both low- and high-affinity TCRs. Thus, comparison of the memory response to two epitopes derived from the same viral antigen and presented through the same MHC class I allele suggests that immunodominance may correlate with the capacity to maintain a broad TCR repertoire.


Address correspondence to Maria G. Masucci, Microbiology and Tumor Biology Center, Karolinska Insitute, S-171 77 Stockholm, Sweden. Phone: 46-8-728-64-00; FAX: 46-8-33-04-98.

The authors are indebted to Andrew J. McMichael for helpful comments on the manuscript.

This investigation was supported by grants from the Swedish Cancer Society, the Pediatric Cancer Foundation, the Karolinska Institute, and the Magnus Bergwal Stiftelse, Stockholm, Sweden. V. Levitsky and M.P. Imreh are supported by fellowships from the Cancer Research Institute, New York and Concern Foundation, Los Angeles. P.-O. de Campos-Lima was partially supported by a fellowship from the Swedish Royal Academy of Sciences. The research in the laboratory of RG was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC).

The first two authors have contributed equally to this work and are placed in alphabetical order.

1 Abbreviations used in this paper: EBNA, Epstein-Barr virus nuclear antigen; CDR3, third complementarity determining region; FW, framework; LCL, lymphoblastoid cell lines.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS